Business hours

Monday - Friday 8am to 4:30pm
After hours or weekends if required by protocol

Horario de oficina

Lunes - Vienes 8 am a 4.30 pm
Fuera de horario o fines de semana si lo requiere el protocolo


(305) 456-9062


Clinical studies

Crohn’s Disease

A Phase IIa, randomized, double-blind, placebo-controlled trial to evaluate the safety, efficacy, pharmacokinetics, and pharmacodynamics of BI 706321 orally administered for 12 weeks in patients with Crohn’s Disease (CD) receiving ustekinumab induction treatment.

Age group: From 18 to 75 years old
Gender: Male or Female
Duration: Up to 1 year approximately
Compensation: Up to $2,000

About the Study
The purpose of this trial is to investigate BI 706321 in subjects with Crohn’s disease. The investigational trial drug is being developed to see if it can improve the symptoms of Crohn’s
when taken with ustekinumab. The study drug has been given to healthy adults in other studies and has been generally well tolerated by those participants.

What will the study involve?
The study will involve regular visits about 16 times. Be randomly assigned to a “study medication”. You will have an equal chance of receiving either investigational medication or a placebo. The placebo looks the same as the investigational medication but contains no active ingredients. Neither you nor the study doctor will know which study medication you are receiving.

Who can Participate?
Participants must be male or female from 18 to 75 years old with a diagnosis of CD for at least 3months prior to Visit 1, as confirmed at any time in the past by endoscopy and/or radiology and supported by histology.

Where is the study taking place?
The study is being conducted at our site in Palmetto Medical Plaza.

Current Clinical Research Study Request

Enter your full legal name

Clinical studies



Monday - Friday 9am to 4:30pm
After hours or weekends if required by protocol

Main Line

(305) 456-9141

24 Hour Phone

786) 214-1433


Palmetto Medical Plaza 7100 West 20th Avenue, Suite 411 Hialeah, FL 33016

Email Us